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SUMMARY. Rabeprazole sodium (RAB) is an anti-secretory agent which inhibits the enzyme H+/K+ AT-
Pase, present in the stomach parietal cells. The aim of this work is to develop and validate a simple and
fast ultraviolet spectrophotometric method (UV) for quantification of RAB in pharmaceutical formulation
and compare it with a capillary electrophoresis (CE) one, previously validated. The UV technique was ap-
plied using water (pH 10.0) as diluent and the determinations were made at λ = 291 nm. The method
showed good linearity (r = 0.9997) in the concentration range of 6.0 to 18.0 μg ml–1. The intra- and inter-
day precision data demonstrated the method has good repeatability (RSD = 0.52 and 0.82, respectively).
Accuracy and specificity were also evaluated and results were satisfactory. The detection and quantitation
limits were 0.32 and 0.95 μg ml–1, respectively. Both methods demonstrated to be adequate for the intend-
ed purpose.
INTRODUCTION
Rabeprazole (±)-sodium 2-[[4-(3-methoxy-
propoxy)-3-methylpyridine-2-yl]methylsulfinyl]-
1H-benzimidazole (RAB) is a proton pump in-
hibitor that covalently binds and inactivates the
gastric parietal cell proton pump (H+/K+ AT-
Pase). It has proven efficacy in healing, symp-
tom relief and prevention of relapse of gastric
ulcer, duodenal ulcer and gastro-oesophageal
reflux disease 1. Another great activity RAB has
is against Helicobacter pylori, an organism
strongly associated with peptic ulcer disease.
There are several different mechanisms sup-
posed for this, but they are not well understood
2,3. Since it is an acid labile drug, it is commer-
cialize in enteric coated tablets 4. The structural
formula of RAB is given in Figure 1.
The literature survey reveals a crescent num-
ber of publications related to RAB determination
in the pharmaceutical dosage form. The meth-
ods applied were: liquid chromatography 5,6,
voltametry 7, CE in aqueous media 8 and deriva-
tive spectrophotometry 9. The dissolution test of
RAB tablets was also published 10, but descrip-
tions on the drug have not appeared in any
pharmacopeia up to now. The identification of
six impurities in RAB bulk substance was per-
formed by LC-MS and spectral data (IR, NMR) 11
and, recently, three photodegradation products
were isolated and elucidated 12.
Although the work of El-Gindy et al. 5 com-
prises also a derivative ratio spectra method,
very useful for stability indication, the method
proposed in this work is simple, fast, could be
applied in routine analysis without sophisticated
tools and was not available yet. 
Figure 1. Chemical structure of Rabeprazole Sodium.
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The aim of this study is to develop and vali-
date UV method for RAB determination in coat-
ed tablets. This method was compared to a CE
one 8, which was previously validated with the
same purpose. The validation procedures will
follow the ICH and USP guidelines 13,14, evaluat-
ing the parameters specificity, linearity, preci-
sion, accuracy and detection and quantitation
limits.
MATERIALS AND METHODS
Chemicals
RAB reference standard was supplied by
Janssen-Cilag (Buenos Aires, Argentine). The
coated tablets (Pariet®), containing 10 mg of
RAB, were obtained commercially. The excipi-
ents of the pharmaceutical formulation were
mannitol, hydroxypropyl cellulose, magnesium
oxide, low-substituted hydroxypropyl cellulose,
magnesium stearate, ethylcellulose, hydrox-
ypropyl methylcellulose phthalate, diacetylated
monoglycerides, talc, titanium dioxide, carnauba
wax, and ferric oxide (red) as a coloring agent.
All of them were obtained from different local
distributors. Water was purified using
Millipore® system and its pH was adjusted to
10.0 with ammonium hydroxide analytical grade
(Grupo Química, Brazil).
Apparatus and conditions
A Shimadzu UV-160A double-beam spec-
trophotometer with 1 cm quartz cells and data
processing capacity was used. The determina-
tions were made at λ = 291 nm and scan speed
of 480 nm min–1. The Digimed potenciometer,
model DM-20 (São Paulo, Brazil) was used to
determine the water pH before the preparation
of all solutions.
Specificity 
The specificity of the method was evaluated
through the analysis of a placebo mixture solu-
tion, prepared with the excipients of the phar-
maceutical formulation in their usual concentra-
tion. 
Linearity
Aliquots of a 100 µg ml–1 solution of RAB
reference standard were transferred to 25 ml
volumetric flasks to obtain the final concentra-
tions of 6.0, 8.0, 10.0, 12.0, 14.0, 16.0 and 18.0
µg ml–1. Each solution was prepared in tripli-
cate. The linearity was evaluated by linear re-
gression analysis, which was calculated by the
least square regression method.
Precision
Five tablets were transferred to 500 ml volu-
metric flask containing 50 ml of water pH 10.0
and shaken for 20 min in ultrasonic bath. The
volume was completed with the same solvent.
The solution was filtered using quantitative pa-
per and also with nylon membrane (0.45 µm)
before diluted to 12 µg ml–1 (six replicates each
day). New solutions were prepared in three
days for inter-day precision evaluation.
Accuracy
The accuracy of the methods was evaluated
through the recovery test. From a RAB standard
solution of 25 µg ml–1, aliquots of 2.0, 4.0 and
6.0 ml were taken and transferred to 25 ml volu-
metric flasks containing 3.0 ml of the sample so-
lution at 100 µg ml–1 (prepared as cited above).
The volume was completed with water pH 10.0
(adjusted with ammonium hydroxide), obtaining
the final concentrations of 14.0. 16.0 and 18.0
µg ml–1, respectively. The concentrations
reached were into the standard curve. Each so-
lution was done in triplicate.
RESULTS AND DISCUSSION
In the beginning of the development of the
method, different solvents were tested, such as
water, methanol and ethanol. Water was consid-
ered the best since it had a great capability to
disintegrate the tablets and the absorbance of
the aqueous solutions of RAB was high. Be-
sides, it does not offer toxicological risks and is
not expensive. The adjust in pH was necessary
since RAB is unstable under acid conditions. 
The original UV spectrum was demonstrated
in Figure 2. It is possible to observe the well-de-
fine peak at 291 nm. The specificity test demon-
strated the placebo solution exhibited some in-
terference in the wavelength of analysis, what
Figure 2. UV spectra of RAB reference standard (a)
and placebo (b), without filtration, both in water (pH
10.0), concentration of 12 µg ml–1.
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would impede the use the method. New investi-
gations were performed and it was found that
the UV method could be applied for this deter-
mination if the sample aqueous solution was fil-
tered with nylon membrane of 0.45 µm (Fig. 3).
Otherwise, the titanium dioxide, one of the ex-
cipients, which was in dispersion, would cause
interference in the absorbance. So, it was neces-
sary to adopt the filtration step, which did not
represent a complex procedure. On the other
hand, the centrifugation was not adopted since
it would add another instrument in the analysis
and it was not an objective.
The results from linearity are demonstrated
in Table 1. The data were validated by means of
analysis of variance (ANOVA), which demon-
strated significative linear regression and no-sig-
nificative linearity deviation (p<0.05). 
From this data, it was possible to calculate
the detection and quantitation limits 13. The re-
sults found were LOD = 0.32 µg ml–1, LOQ =
0.95 µg ml–1. These low values indicated the
Amount (%) RSD
Method
First day* Second day* Third day* Mean Inter-days
102.40 101.42 102.27
102.40 101.35 102.94
102.33 101.29 102.74
UV
102.14 101.35 103.14
102.26 0.82
102.14 101.42 103.74
102.53 101.10 103.94
Mean 102.32 101.32 103.13
RSD 0.15 0.12 0.61
CE mean (RSD)(8) 101.41 (1.89) 100.49 (1.47) 101.27 (1.82) 101.06 1.69
Table 2. Determination of commercial samples of RAB by UV spectrophotometric method (λ 291 nm, water as
diluent) and CE. Electrophoretic conditions: sodium tetraborate buffer 10 mM (pH 9.0), voltage of 20 kV, UV
detection – 291 nm (8) – precision test; *mean of three determinations.
Figure 3. UV spectra of RAB reference standard (a)
and placebo (b), both in water (pH 10.0), concentra-
tion of 12 µg ml–1, after filtration with nylon mem-
brane.
Feature UV
Regression equation y = 0.042 x + 0.0008
Correlation coefficient (r) 0.9997
Linear range (µg ml–1 ) 6.0-18.0
Table 1. Results of the standard curve of UV spec-
trophotometric method (λ 291 nm) for RAB.
good sensitivity of the proposed method. The
determinations of commercial samples showed
excellent precision. The results obtained are list-
ed in Table 2. All values for relative standard
deviation are below 2.0%. In the sample prepa-
ration, it was not possible to use the powder of
tablets, as usual, since the coating could not be
powdered. So, it was adopted the solution ob-
tained from five tablets, which were dissolved
together in a volumetric flask. Using this num-
ber of units, the sampling was representative
and the amount of excipients in suspension was
not big enough to impede or delay the filtration
step. 
The evaluation of accuracy, made through
the recovery test, showed a mean recovery of
99.65% (Table 3).
Comparison of methods
The CE method, previously validated 8, ap-
plied the capillary zone electrophoresis (CZE)
separation technique, in which the capillary is
filled with the running buffer solution (10 mM
sodium tetraborate) and the ionic analytes are
separated under high voltage (20 kV). The com-
parison between the UV and the CE methods
was performed by t-Student test. It was found
that the amounts of RAB determined using each
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method were not statistically different (tcalc =
2,01< ttab = 2,77, p < 0.05). It means that both
methods could be used for the same purpose. A
representative electropherogram of RAB is
demonstrated in Figure 4.
Considering that chromatographic methods
are more expensive, time consumer and need
more steps, the proposed UV method is ade-
quate for routine analysis and also cheaper, be-
ing a safe and sensitive alternative for quality
control of RAB in tablets. Another important ap-
plication could be the dissolution studies, which
need rapid and accurate results. The CE method
also has many advantages such as low consume
of solvents, good efficacy and rapid analysis,
but the instrumental are still not available in all
laboratories, mainly for routine use, which may
represent a barrier to apply the method.
CONCLUSIONS
The UV method was validated and demon-
strated to be simple, linear, accurate, precise,
specific and sensitive, which indicates its ade-
quacy to pharmaceutical analysis, being equiva-
lent to the CE one 8 for RAB determination in
coated tablets. 
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Concentration
(µg ml–1)
% of recovery * Mean (%)
Added Found
2.0 1.99 99.50
4.0 4.01 100.25 99.65
6.0 5.95 99.17
Table 3. Recovery test for RAB by UV spectrophoto-
metric method (λ 291 nm), using water pH 10.0 as
diluent; * mean of three determinations.
Figure 4. Representative electropherogram of RAB in
water pH 10.0 (20 µg ml–1). Electrophoretic condi-
tions: sodium tetraborate buffer 10 mM (pH 9.0), volt-
age of 20 kV, fused-silica capillary of 48 cm total
length, UV detection – 291 nm 8.
